Longitudinal Study of Urea Cycle Disorders
This study is a long-term look at rare, inherited conditions known as urea cycle disorders (UCDs). These conditions affect how the body processes protein, leading to a build-up of a harmful waste product called ammonia. The study aims to understand the natural course of UCDs, how they progress over time, and how different treatments work. Researchers will follow a large group of people with various UCDs to learn more about their health, development, and how they respond to care. The goal is to better predict and manage these conditions, ultimately improving the lives of those affected.
At a glance
What is this study about?
Urea cycle disorders (UCDs) are a group of uncommon conditions that people are born with, passed down through families. They affect how your body deals with proteins from the food you eat. Normally, when your body breaks down protein, it produces a waste product called ammonia. Your liver then changes this ammonia into something called urea, which your body can safely get rid of through your urine.
However, if you have a UCD, your body isn't able to change ammonia into urea properly. This means ammonia can build up to harmful levels in your blood. When too much ammonia reaches your brain, it can cause serious problems, including brain damage or even be life-threatening. Children and babies with UCDs can experience symptoms like sickness, extreme tiredness, or even falling into a coma during these ammonia build-ups.
This study aims to follow a large number of people with different types of UCDs over many years. The main goal is to understand how these conditions develop over time, how different treatments work, and what the overall health and development consequences are. By carefully watching these individuals, researchers hope to better understand why some people get symptoms and others don't, and to find ways to predict and prevent future health problems.
Key takeaways
- This is a long-term study looking at rare inherited conditions called urea cycle disorders (UCDs).
- It aims to understand how UCDs progress, how treatments help, and what long-term health is like.
- Participation involves regular clinic visits for check-ups, blood tests, and assessments of thinking skills.
- The study doesn't involve new medicines; it observes existing conditions and treatments.
- The information gained could help improve care for people with UCDs in the future.
Who may be eligible?
This study is looking for people who have been diagnosed with one of several specific urea cycle disorders. This diagnosis must be confirmed through certain tests, such as finding a specific genetic change (a 'pathogenic mutation'), or having low levels of particular enzymes in the liver which are important for processing ammonia. In some cases, high levels of ammonia in the blood, combined with a close family member also having a similar diagnosis, are also part of the criteria.
Specifically, the study is recruiting individuals with diagnoses of NAGS deficiency, CPS I deficiency, OTC deficiency, AS deficiency (Citrullinemia), AL deficiency (Argininosuccinic Aciduria, ASA), or ARG deficiency (Hyperargininemia). The diagnosis for each of these conditions has very specific medical requirements that your doctor would be able to check against your medical records.
If you have received a medical diagnosis of one of these conditions, and your doctor can confirm the specific details of your diagnosis match the study's requirements, then you might be eligible to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Do you have a doctor's diagnosis of a urea cycle disorder?
- Has your diagnosis been confirmed by specific genetic tests or enzyme levels?
- Do you have high levels of ammonia in your blood, and a close relative with a UCD?
- Are you able to attend regular follow-up appointments (every 3 or 6 months)?
- Are you comfortable with blood tests and psychological testing?
What does participation involve?
If you join this study, your first visit will involve a detailed chat about your medical history and diet, as well as physical and neurological (nerve and brain) examinations. You'll also have some tests to look at your thinking skills and blood tests. After this first visit, you'll have follow-up appointments. These visits will typically last about 2-3 hours each.
How often you're seen depends on when your UCD symptoms first appeared. If your symptoms started when you were a baby, you'll have check-ups every 3 months until you're two years old, and then every 6 months after that. If your symptoms started later in life, you'll be seen every 6 months. Tests that look at your thinking skills will happen every 2 years and can take from 30 minutes for younger children up to 3 hours, depending on the types of tests given. This study is expected to continue until 2025.
Potential risks and benefits
Locations (15)
- University of California, Los AngelesVerified postcodeLos Angeles, United States· Recruiting
- Stanford University Medical CenterVerified postcodeStanford, United States· Recruiting
- Children's Hospital ColoradoVerified postcodeAurora, United States· Recruiting
- Children's National Medical CenterVerified postcodeWashington D.C., United States· Recruiting
- Children's Hospital Boston (UCDC New England Center)Verified postcodeBoston, United States· Recruiting
- University of MinnesotaVerified postcodeMinneapolis, United States· Recruiting
- Icahn School of Medicine at Mount SinaiVerified postcodeNew York, United States· Recruiting
- Case Western Medical CollegeVerified postcodeCleveland, United States· Recruiting
- Oregon Health and Science UniversityVerified postcodePortland, United States· Recruiting
- Children's Hospital of PhiladelphiaVerified postcodePhiladelphia, United States· Recruiting
- Baylor College of MedicineVerified postcodeHouston, United States· Recruiting
- Children's Hospital and Regional Medical CenterVerified postcodeSeattle, United States· Recruiting
Common questions
What is a urea cycle disorder (UCD)?
UCDs are rare inherited conditions where the body can't properly get rid of a harmful waste product called ammonia, which can build up to unhealthy levels.
Why is this study being done?
This study aims to understand how UCDs progress over time, how treatments work, and what the long-term health outcomes are for people living with these conditions.
Will I have to take new medicine?
This is an observational study, meaning you will not be given new medicines as part of the study. It focuses on understanding your condition and current treatments.
Who can take part in this study?
The study is for people of any age with a confirmed diagnosis of specific types of urea cycle disorders. Your doctor can help determine if your diagnosis matches the entry requirements.
How long will I be in the study?
The study is ongoing until 2025, and your participation will involve regular visits every few months or twice a year, depending on your specific condition and age.
How to find out more
Jennifer Seminara, MPH
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.